The key to effective capital allocation is using an objective framework to drive the analysis, prioritization, and execution.
CFOs have to balance unforeseen COVID-driven capital issues with the need for investment that drives long-term value creation.
The Japanese conglomerate's investment in a company whose CEO's business dealings are under fire won't derail its continuing success: Opinion.
Acquisitions are a zero-sum game: both buyer and seller need to feel they are getting a good deal. Unfortunately, buyers usually pay too much.
Your company’s strategy isn’t static, so your capital allocations shouldn’t be either.
The big semiconductor distributor charts a broad new strategic path and employs key financial strategies to overcome challenging times.
The incoming finance chief has an "impossible" problem in funding needed capex on top of a huge share buyback and dividend hike, analyst firm says.
The acquisition of Novartis' stake will give GSK full control over the revenues from such products as Sensodyne toothpaste and the Excedrin pain reliever.
If the U.S. Tax Cuts and Job Act doesn’t push companies to invest more in capex, a “stagflation scenario” could ensue.
What does your capital deployment strategy say about your growth expectations?
Buyback ROI, a tool first introduced on CFO.com, can be used by executives and investors to determine when buybacks are more likely to be successful.
Prospective tax changes from President-elect Trump will cause companies to change how they allocate and distribute capital.
